{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:56:14Z","timestamp":1793321774488,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.beem.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T02:01:17Z","timestamp":1489024877000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Growth hormone deficiency in treated acromegaly and active Cushing's syndrome"],"prefix":"10.1016","volume":"31","author":[{"given":"Anna Maria","family":"Formenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Maffezzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Doga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2017.03.002_bib1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12020-014-0278-y","article-title":"Impaired growth hormone secretion associated with low glucocorticoid levels: an experimental model for the Giustina effect","volume":"47","author":"Giustina","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.03.002_bib2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(07)60673-4","article-title":"Hypopituitarism","volume":"369","author":"Schneider","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2017.03.002_bib3","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","article-title":"Determinants of clinical outcome and survival in acromegaly","volume":"41","author":"Rajasoorya","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Rajasoorya RC et Gamble GD. Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib6","first-page":"1","article-title":"Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors","volume":"25","author":"Giustina","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.beem.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","article-title":"A\u00a0consensus on the diagnosis and treatment of acromegaly complications","volume":"16","author":"Melmed","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1460067","article-title":"KIMS International Study Board of KIMS Study Group. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease","volume":"146","author":"Feldt-Rasmussen","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/jc.2007-2673","article-title":"Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly","volume":"93","author":"Norrman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/jc.2012-2477","article-title":"GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency","volume":"97","author":"Giavoli","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1210\/jc.2014-1013","article-title":"Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis","volume":"99","author":"Tritos","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib13","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.03.002_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1530\/eje.0.1330646","article-title":"Influence of thyroid hormones on the regulation of growth hormone secretion","volume":"133","author":"Giustina","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib15","first-page":"1369","article-title":"Effects of sex and age on the growth hormone response to galanin in healthy human subjects","volume":"76","author":"Giustina","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000127172","article-title":"Effects of food deprivation on the GH axis: immunocytochemical and molecular analyses","volume":"65","author":"Brogan","year":"1997","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Acromegaly Consensus Group. Guidelines for acromegaly management: an update","volume":"94","author":"Melmed","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11102-010-0269-9","article-title":"Current management practices for acromegaly: an international survey","volume":"14","author":"Giustina","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"e36411","DOI":"10.1371\/journal.pone.0036411","article-title":"Meta-analysis on the effects of octreotide on tumor mass in acromegaly","volume":"7","author":"Giustina","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12020-014-0462-0","article-title":"Optimal use of pegvisomant in acromegaly: are we getting there?","volume":"48","author":"Giustina","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.03.002_bib21","first-page":"526","article-title":"Criteria for cure of acromegaly: a consensus statement","volume":"85","author":"Giustina","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"E746","DOI":"10.1227\/NEU.0000000000000068","article-title":"Post-surgical monitoring of acromegaly","author":"Giustina","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2017.03.002_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1530\/EJE-11-0657","article-title":"GH deficiency in patients after cure of acromegaly by surgery alone","volume":"165","author":"Yamada","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/EJE-14-0304","article-title":"Clinical predictors of growth hormone deficiency in surgically cured acromegalic patients","volume":"171","author":"Ku","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EJE-09-0222","article-title":"Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments","volume":"161","author":"Ronchi","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib26","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1210\/jcem.85.7.6699","article-title":"Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly","volume":"85","author":"Biermasz","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-09-0506","article-title":"Long term effect of external pituitary irradiation on IGF1 levels in patients with acromegaly free of adjunctive treatment","volume":"161","author":"Mullan","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib28","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1210\/jc.2008-0135","article-title":"The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma","volume":"93","author":"Losa","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/jc.2009-1611","article-title":"Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement","volume":"95","author":"Miller","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF03349263","article-title":"Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults","volume":"31","author":"Giustina","year":"2008","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.03.002_bib31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/eje.1.02163","article-title":"GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion","volume":"154","author":"van der Klaauw","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2265.2001.01189.x","article-title":"The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients","volume":"54","author":"Murray","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/jc.2002-021094","article-title":"The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval","volume":"88","author":"Darzy","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.beem.2017.03.002_bib34","first-page":"118","article-title":"Endocrine consequence of brain irradiation","volume":"14","author":"Toogood","year":"2014","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.beem.2017.03.002_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2265.2006.02757.x","article-title":"Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients","volume":"66","author":"van der Klaauw","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12020-013-0106-9","article-title":"Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study","volume":"46","author":"Yedinak","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.03.002_bib37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12020-014-0166-5","article-title":"Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?","volume":"47","author":"Anagnostis","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.03.002_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11102-006-0410-y","article-title":"Growth hormone deficiency in the adult","volume":"9","author":"Doga","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.03.002_bib39","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1210\/jc.2004-0545","article-title":"Growth hormone and cardiovascular risk factors","volume":"90","author":"Gola","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/jc.2013-2394","article-title":"Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH\u2013an update","volume":"99","author":"Gazzaruso","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1994.tb02452.x","article-title":"Decreased psychological well-being in adult patients with growth hormone deficiency","volume":"40","author":"Ros\u00e9n","year":"1994","journal-title":"Clincal Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib42","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.060112","article-title":"Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy","volume":"21","author":"Mazziotti","year":"2006","journal-title":"J\u00a0Bone Mineral Res"},{"key":"10.1016\/j.beem.2017.03.002_bib43","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jc.2006-2547","article-title":"Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis","volume":"92","author":"Maison","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib44","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/jc.2008-2332","article-title":"Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies","volume":"94","author":"Mazziotti","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ghir.2010.05.003","article-title":"Growth hormone status predicts left ventricular mass in patients after cure of acromegaly","volume":"20","author":"Wexler","year":"2010","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.beem.2017.03.002_bib46","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(97)24015-8","article-title":"Haemodynamic effects of intravenous growth hormone in congestive heart failure","volume":"349","author":"Volterrani","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2017.03.002_bib47","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0002-8703(96)90552-9","article-title":"Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy","volume":"131","author":"Giustina","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.beem.2017.03.002_bib48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.03.002_bib49","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1359\/JBMR.050603","article-title":"Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women","volume":"20","author":"Bonadonna","year":"2005","journal-title":"J\u00a0Bone Mineral Res"},{"key":"10.1016\/j.beem.2017.03.002_bib50","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2008-0791","article-title":"Prevalence of vertebral fractures in men with acromegaly","volume":"93","author":"Mazziotti","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib51","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jc.2014-2937","article-title":"Bone turnover, bone mineral density and fracture risk in acromegaly: a meta-analysis","volume":"100","author":"Mazziotti","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib52","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2013-1460","article-title":"Vertebral fractures in patients with acromegaly: a 3-year prospective study","volume":"98","author":"Mazziotti","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11102-007-0069-z","article-title":"Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency","volume":"11","author":"Mazziotti","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.03.002_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-10-0125","article-title":"Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency","volume":"163","author":"Mazziotti","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib55","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1530\/EJE-14-0097","article-title":"Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism","volume":"170","author":"Mazziotti","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib56","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2265.2012.04361.x","article-title":"Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly","volume":"77","author":"Lin","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-08-0496","article-title":"Cardiac manifestations of GH deficiency after treatment for acromegaly: a comparison to patients with biochemical remission and controls","volume":"159","author":"van der Klaauw","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib58","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1210\/jc.2008-2671","article-title":"Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly","volume":"94","author":"Wexler","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4158\/EP11134.OR","article-title":"Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders","volume":"18","author":"Valassi","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2017.03.002_bib60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11102-009-0186-y","article-title":"Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly","volume":"12","author":"van der Klaauw","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.03.002_bib61","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/EJE-14-0515","article-title":"Effect of long-term growth hormone replacement therapy on cardiovascular outcomes in growth hormone deficient patients previously treated for acromegaly - a sub-analysis from the Dutch national registry of growth hormone treatment in adults","volume":"171","author":"van Bunderen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tem.2014.10.005","article-title":"Growth hormone deficiency in treated acromegaly","volume":"26","author":"Mazziotti","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2826.1996.04779.x","article-title":"Dexamethasone increases growth hormone (GH)-releasing hormone (GHR) receptor mRNA levels in culture rat anterior pituitary cells","volume":"8","author":"Tamaki","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2017.03.002_bib64","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2826.2000.00446.x","article-title":"Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression","volume":"12","author":"Tamura","year":"2000","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib65","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/endo.138.6.5184","article-title":"Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression","volume":"138","author":"Miller","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.03.002_bib66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000127109","article-title":"Immunocytochemical and molecular analysis of the effects of glucocorticoid-treatment on the hypothalamic-somatotropic axis in the rat","volume":"64","author":"Fife","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2017.03.002_bib67","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0024-3205(94)00478-B","article-title":"Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment","volume":"56","author":"Voltz","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.beem.2017.03.002_bib68","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/07435809509030486","article-title":"Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats","volume":"21","author":"Giustina","year":"1995","journal-title":"Endocr Res"},{"key":"10.1016\/j.beem.2017.03.002_bib69","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0026-0495(95)90269-4","article-title":"Galanin counteracts the inhibitory effects of glucocorticoids on growth hormone secretion in the rat","volume":"44","author":"Giustina","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2017.03.002_bib70","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1210\/endo-127-6-2705","article-title":"Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies","volume":"127","author":"Wehrenberg","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.03.002_bib71","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1210\/endo.143.4.8716","article-title":"Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment","volume":"143","author":"Tulipano","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.03.002_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.regpep.2004.07.027","article-title":"The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat","volume":"15","author":"Tulipano","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.beem.2017.03.002_bib73","first-page":"206","article-title":"Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects","volume":"122","author":"Giustina","year":"1990","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib74","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jcem-71-3-580","article-title":"Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone releasing hormone stimulated growth hormone secretion in normal men","volume":"71","author":"Giustina","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib75","first-page":"1445","article-title":"Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement","volume":"130","author":"Wehrenberg","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.03.002_bib76","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1210\/jcem-67-6-1258","article-title":"Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men","volume":"67","author":"Kaufmann","year":"1988","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000183874","article-title":"Effect of hydrocortisone on the growth hormone (GH) response to GH-releasing hormone in acromegaly","volume":"41","author":"Giustina","year":"1994","journal-title":"Hormone Res"},{"key":"10.1016\/j.beem.2017.03.002_bib78","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0026-0495(93)90229-H","article-title":"Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly","volume":"42","author":"Giustina","year":"1993","journal-title":"Metab - Clin Exp"},{"key":"10.1016\/j.beem.2017.03.002_bib79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1378\/chest.127.2.515","article-title":"Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment","volume":"127","author":"Malerba","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.beem.2017.03.002_bib80","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2265.1991.tb00933.x","article-title":"Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation","volume":"35","author":"Giustina","year":"1991","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib81","first-page":"1301","article-title":"Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy","volume":"74","author":"Giustina","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib82","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/07435809309035407","article-title":"Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease","volume":"19","author":"Giustina","year":"1993","journal-title":"Endocr Res"},{"key":"10.1016\/j.beem.2017.03.002_bib83","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1210\/jcem.85.3.6531","article-title":"Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone","volume":"85","author":"Terzolo","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib84","first-page":"439","article-title":"Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons","volume":"76","author":"Lima","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib85","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2013.5","article-title":"Glucocorticoids and the regulation of growth hormone secretion","volume":"9","author":"Mazziotti","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib86","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1159\/000064764","article-title":"Mechanisms of steroid impairment of growth","volume":"58","author":"Hochberg","year":"2002","journal-title":"Hormone Res"},{"key":"10.1016\/j.beem.2017.03.002_bib87","first-page":"403","article-title":"Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition","volume":"83","author":"Touati","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib88","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jc.2007-0544","article-title":"Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study","volume":"92","author":"Bechtold","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib89","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2002-030011","article-title":"Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib90","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1542\/peds.2007-3273","article-title":"Inhaled corticosteroids and asthma control in children: assessing impairment and risk","volume":"123","author":"Rachelefsky","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2017.03.002_bib91","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","article-title":"Drug-induced osteoporosis: mechanisms and clinical implications","volume":"123","author":"Mazziotti","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2017.03.002_bib92","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tem.2006.03.009","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"17","author":"Mazziotti","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib93","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.03.002_bib94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bone.2005.07.002","article-title":"Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy","volume":"38","author":"Malerba","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.beem.2017.03.002_bib95","first-page":"E366","article-title":"Physiological hypercortisolemia increases proteolysis, glutamine and alanine production","volume":"255","author":"Darmaun","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.beem.2017.03.002_bib96","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2265.2004.01976.x","article-title":"Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome","volume":"60","author":"Tzanela","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib97","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2265.2003.01922.x","article-title":"Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion","volume":"60","author":"Carroll","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib98","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/eje.1.02329","article-title":"Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease","volume":"156","author":"Pecori Giraldi","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib99","first-page":"505","article-title":"Treatment of Cushing disease: overview and recent findings","volume":"21","author":"Mancini","year":"2010","journal-title":"J\u00a0Ther Clin Risk Manag"},{"key":"10.1016\/j.beem.2017.03.002_bib100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-09-0836","article-title":"Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease","volume":"162","author":"H\u00f6ybye","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.03.002_bib101","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","article-title":"Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous Cushing's disease or non-functioning pituitary adenoma","volume":"95","author":"Webb","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib102","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000321245","article-title":"Growth hormone treatment in children on chronic glucorticoid therapy","volume":"20","author":"Savage","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.03.002_bib103","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1210\/jcem.83.8.5036","article-title":"Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study","volume":"83","author":"Allen","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib104","first-page":"2492","article-title":"Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy","volume":"30","author":"Simon","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.beem.2017.03.002_bib105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1210\/jc.2009-0979","article-title":"Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone","volume":"95","author":"Bechtold","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib106","first-page":"122","article-title":"Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone","volume":"80","author":"Giustina","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI114694","article-title":"Human growth hormone prevents the protein catabolic side effects of prednisone in humans","volume":"86","author":"Horber","year":"1990","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.beem.2017.03.002_bib108","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/jc.2007-2333","article-title":"Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients","volume":"93","author":"Burt","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib109","first-page":"243","article-title":"The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome","volume":"82","author":"Bowes","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib110","first-page":"3262","article-title":"Linear growth and final height after treatment for Cushing's disease in childhood","volume":"85","author":"Lebrethon","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib111","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tem.2011.09.001","article-title":"Diabetes in Cushing syndrome: basic and clinical aspects","volume":"22","author":"Mazziotti","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.03.002_bib112","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diab.40.1.141","article-title":"Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans","volume":"40","author":"Horber","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2017.03.002_bib113","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF00866769","article-title":"Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone","volume":"10","author":"Mauras","year":"1996","journal-title":"Pediatr Nephrol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:51:33Z","timestamp":1761497493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X17300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1521690X17300088"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2017.03.002","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone deficiency in treated acromegaly and active Cushing's syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}